InsidersTradesSigma
모아라이프플러스 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 모아라이프플러스 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 모아라이프플러스 has published 2 reports. Market capitalisation: €15.9bn. The latest transaction was filed on 15 April 2026 (Other). Among the most active insiders: 모아데이타. The full history is accessible without an account.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,188 of 27,807 companies
10.3
score / 100
Value4
Quality16
FCF yld-39%
Earn yld-82%
EV/EBITDA·
ROE-22%
Gross mgn17%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 15 April 2026
About 모아라이프플러스
모아라이프플러스 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX. It focuses on developing innovative solutions to enhance patients' quality of life.